2 results
Approved WMOCompleted
Primary objective:The primary objective of the trial is to evaluate efficacy, as measured by overall survival (OS), of gemcitabine in combination with TH-302 compared to gemcitabine in combination with placebo in subjects with previously untreated…
Approved WMOPending
The purpose of this study is to compare the good and bad effects of bermekimab to the good and bad effects of adalimumab and/or placebo. Adalimumab is a drug already used to treat moderate to severe hidradenitis suppurativa (HS).